Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

Pigmentation

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

Assessment of the Mouth

Assessment of the Mouth

A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

Dermatology and therapy·2026

Same author

Representation of Topical Corticosteroid Withdrawal and Steroid Phobia on TikTok and YouTube Shorts: A Mixed-Methods Content Analysis.

The Australasian journal of dermatology·2026

Same author

Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.

Frontiers in medicine·2026

Same author

Lifestyle, medication use, and age considerations with acne vulgaris: A prospective study.

JEADV clinical practice·2026

Same author

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis.

JCI insight·2025

Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025

Same journal

The role of circulating tumor DNA in the management of melanoma: a literature review.

Melanoma research·2026

Same journal

Schisandrin C suppresses melanoma growth and metastasis through modulation of Rap1-related and phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin signaling pathways.

Melanoma research·2026

Same journal

Factors to consider in a primary care setting when using convolutional neural network tools for melanoma diagnostics: a retrospective analysis of images and patient characteristics.

Melanoma research·2026

Same journal

Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.

Melanoma research·2026

Same journal

Twenty-one years of cutaneous melanoma: stage shift, anatomical patterns and diagnostic trends from a Southern European tertiary center.

Melanoma research·2026

Same journal

Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study.

Melanoma research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Screening for melanoma.

Mary-Katharine M Collins¹, Aaron M Secrest, Laura K Ferris

¹aDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA bDepartment of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Melanoma Research

|July 8, 2014

Summary

This summary is machine-generated.

Targeted melanoma screening is recommended for high-risk individuals in the USA due to rising incidence. This approach optimizes resource allocation and improves early detection rates for those most susceptible to melanoma.

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Experiment Videos

Last Updated: Apr 27, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Area of Science:

Dermatology
Oncology
Public Health

Background:

Melanoma incidence is increasing, yet the USA lacks uniform screening guidelines.
Melanoma screening is low-morbidity but most impactful in high-risk populations.
Screening lower-risk individuals can lead to increased costs and unnecessary procedures.

Purpose of the Study:

Advocate for targeted melanoma screening strategies.
Identify high-risk patient populations for effective screening.
Improve early detection of melanoma in vulnerable groups.

Main Methods:

Literature review on current melanoma screening practices.
Analysis of risk factors for melanoma incidence and mortality.
Evaluation of cost-effectiveness and resource allocation in screening.

Main Results:

Current screening lacks uniformity, potentially leading to inefficiencies.
High-risk patients benefit most from screening interventions.
Targeted screening can mitigate costs and unnecessary biopsies.

Conclusions:

Implementing targeted melanoma screening is crucial for effective public health strategies.
Focusing on high-risk individuals optimizes dermatologic resources.
Screening should prioritize patients at highest risk and those least likely to self-detect melanoma.